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CLINICAL INVESTIGATION
Identification of a monocyte phagocytic defect in a
subpopulation of patients with nephritis
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Identification of a monocyte phagocytic defect in a subpopulation of
patients with nephritis. Experimental studies have demonstrated the
cardinal role played by the mononuclear phagocyte system in the
removal of antigen-antibody complexes. To assess the functional capac-
ity of phagocytes in patients with renal disease, 33 normal subjects, 10
patients with mesangial proliferative glomerulonephritis. 8 patients with
membranous nephropathy, and 8 patients with moderately severe
chronic renal failure were studied by an in vitro assay, measuring the
ability of isolated monocytes to ingest sheep erythrocytes coated with
IgG antibody and to phagocytize latex beads. Monocytes from four
patients with mesangial proliferative glomerulonephritis and one patient
with membranous nephropathy exhibited a subnormal capacity to
ingest the antibody-coated erythrocytes. Additionally, monocytes from
two of the four patients with mesangial proliferative glomerulonephritis
and a defect in ingesting sensitized erythrocytes had a subnormal
capacity to phagocytize latex beads. The results are interpreted in the
context of a hypothesis which suggests that patients with immune
nephritis show various forms of immune deficit.
Identification d'un défaut de phagocytose monocytaire dans une sous-
population de malades avec néphrite. Des etudes expérimentales ont
démontré le role capital jouè par le système phagocytaire mononu-
cléaire dans l'élimination des complexes antigènes-anticorps. Afin
d'évaluer Ia capacité fonctionnelle des phagocytes chez des malades
ayant une maladie rénale, 33 sujets normaux, 10 malades avec une
glomerulonéphrite mésangiale proliferative, 8 malades avec une néph-
ropathie extra-membraneuse, et 8 malades avec une insuffisance rénale
chronique de sévérité moyenne ont été étudiés avec un dosage in vitro.
mesurant Ia capacité de monocytes isolés d'ingerer des erythrocytes de
mouton recouverts d'anticorps IgG et de phagocyter des billes de latex.
Les monocytes de quatre malades ayanl une glomerulonephrite mésan-
giale proliferative et d'un malade ayant une néphropathie extra-mem-
braneuse avaient une capacité insuffisante d'ingerer les érythrocytes
recouverts d'anticorps. De plus, les monocytes de deux des quatre
malades ayant une glomerulonephrite mésangiale proliferative et un
défaut dans l'ingestion des erythrocytes sensibilisés avaient une capa-
cite insuffisante de phagocyter des billes de latex. Ces rCsultats sont
interprétes dans le contexte de l'hypothese suggérant que les malades
ayant une néphrite immune ont diverses formes de deficits
immunitaires.
The deposition of soluble complexes in the glomerulus is one
of the major mechanisms leading to the development of nephri-
tis. There are at least two critical factors which influence the
genesis of immune complex nephritis: the induction of an
antibody response which is suboptimal and allows the forma-
tion of immune complexes in antigen excess and the functional
capacity of the mononuclear phagocyte system to take up and
process antigen-antibody complexes via its Fc receptor. Early
studies have shown that when preformed immune complexes
were infused into the circulation, the bulk of such complexes
was sequestered in the phagocyte systems of the liver and
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spleen [1]; furthermore, it also showed that the system was
subject to saturation [2], and that if complexes were modified
by physicochemical means such that the uptake was dimin-
ished, increased renal deposition would result [3, 4]. The
converse has also been shown, that if the functional capacity of
the system was stimulated by the administration of agents such
as Corynebacterium parvum or zymosan to the host, there
would be reduced deposition of these macromolecules in the
glomeruli, due to an augmented uptake and degradation of the
substances by the hepatic and splenic phagocytes [5, 6]. In
animal models such as in mice injected with lymphochoriocytic
menningitis virus [71, there was evidence of depressed phago-
cytic activity and presumed facilitated deposition of immune
complexes in the kidney. The data in regard to the animal
analogue of lupus nephritis, Fl NZBINZW female mice, are
conflicting in this regard [8—101. While some investigators were
able to define the presence of defective uptake of complexes,
this has not been confirmed by others [8—10]. The most current
study showed that while there may be no difference between
normal mice and the Fl NZB/NZW Fl hybrids in terms of the
uptake of immune complexes, the complexes bound to the
surfaces of phagocytes of Fl NZB/NZW hybrids were more
readily displaced [11]. There is convincing evidence of a defect
in Fc receptor function in human patients with systemic lupus
erythematous (SLE) when they were examined by in vivo
techniques measuring the clearance of radiolabeled complexes
[12]. Subpopulations of patients with nephritis examined by
similar techniques were also found to have a defect in Fc
receptor function [13, 14]. We wish to report in this communica-
tion the identification of a subpopulation of patients with
nephritis who have a demonstrable defect in Fc receptor
function by means of an in vitro assay.
Methods
The following subjects were studied: 33 healthy subjects, 10
patients with mesangial proliferative glomerulonephritis, 8 pa-
tients with membranous nephropathy, and 8 patients with
moderate to severe chronic renal failure from non-immune'
causes. All patients with mesangial proliferative glomerulone-
phritis and membranous nephropathy had renal biopsies with
tissue studies by light, fluorescence, and electronmicroscopy.
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Table 1. Histologic and laboratory characteristics of patients studied
Histologic and laboratory data
Patients with
monocyte defect, no.
Histological
diagnosis
Mesangial proliferative ON
Mesangial proliferative ON
Mesangial proliferative ON
Mesangial proliferative ON
Membranous nephropathy
EAIgO
phago-
cytosis
9/
84 Positive
85 Negative
49 Negative
54 Negative
83 Negative
Patients without
monocyte defect
7 patients
6 patients
8 patients
Membranous nephropathy
Mesangial proliferative ON
Chronic renal failure
2.8 to .6' 0.7 to 14.2 80 to 96 83 to 96 Negative
3.0 to 3.5 1.4 to 3.7' 80 to 86 85 to 91 Positive
(3/6)
3.1 to 4.2° 4.4 to 18.8' 80 to 95" $1 to 95' Negative
Values represent the range of observations.
The term mesangial proliferative glomerulonephritis is used in a
descriptive (and not a nosological) sense to designate renal
biopsy specimens showing diffuse mesangial hypercellularity
and mesangial matrix increase. The patients had no clinical or
serologic evidence of systemic lesions and were not being
treated with steroids or other immunosuppressive drugs. The
relevant clinical characteristics of the patients are shown in
Table 1.
The assay for monocyte Fc receptor-mediated phagocytosis
was done as described by Czop, Fearon, and Austen [151 with
minor modification. Human mononuclear cells were prepared
by the technique of gradient centrifugation on Ficoll-Hypaque
cushions 1161. The mononuclear cells were washed with Hank's
balanced salt solution (HBSS), resuspended in HBSS, and
counted in a hemocytometer. Monocyte monolayers were pre-
pared by layering thoroughly cleaned circular glass cover slips
(15 mm diameter, SGA Scientific, Inc., Bloomfield, New Jer-
sey) with 0.25 ml of a suspension of mononuclear cells (adjusted
to a concentration of 2.2 x 106 cells/mi with RPMI-BSA
medium). The cells were incubated at 37°C >< 60 mm in a 5%
CO2 humidified atmosphere, followed by rinsing to remove
nonadherent cells. Adherent cells were defined by morphology
and the esterase stain and were greater than 95% monocytes.
Sheep erythrocytes (E) were obtained, stored in veronal-buff-
ered saline, pH 7.5 containing 0.1% gelatin, and 0.04 M EDTA.
Erythrocytes coated with IgG antibody (EAIgG) were prepared
by incubating 1 x i09 sheep erythrocytes with an equal volume
of rabbit antisheep hemolysin (Cordis Laboratories, Miami,
Florida) for 30 mm at 37°C anti then 30 mm at 4°C, the titer of
antisheep hemolysin was chosen as a subagglutinating titer and
was approximately 1/100. Monolayers of monocytes were lay-
ered with 0.2 ml of the coated erythrocytes, incubated for 45
mm x 37°C in a CO2 chamber, and then rinsed twice with
HBSS. Washed monoiayers were treated with a pulse of
distilled water to lyse noningested erythrocytes, rinsed in
medium, fixed with 2.5% glutaraldehyde, washed again, and
stained with 4% Giemsa solution, air-dried and mounted on
microscope slides. The number of monocytes ingesting one or
more particles was counted by examining at least 400 mono-
cytes. Triplicates were done for each subject.
Latex bead phagocytosis was assessed by a similar protocol
except that the monocyte monolayers were overlaid with latex
beads (Dow Chemical Co., Indianapolis, Indiana), and phago-
cytosis was assessed by phase contrast microscopy.
Circulating immune complexes were assayed by the solid
phase Clq-assay [17]; reagents were prepared as reported from
our previous studies using the Clq-binding assay [18]. Sera
from the five patients with the Fe receptor defect were assayed
for serum immune complexes by the Raji cell assay [19] done by
Dr. P. Hurtubise, Department of Pathology, University of
Cincinnati Medical Center.
Statistical analysis was done by the unpaired t test.
Results
The results of the assay for m000cyte phagocytosis of EAIgG
particles are shown in Figure 1. In normal subjects the mean (±
SD) percentage of monocytes exhibiting phagocytosis of EAIgG
particles was 89% 5%.
Monocytes of patients with chronic renal failure showed a
normal capacity to ingest antibody-coated erythrocytes. The
monocytes of only one of the eight patients with mernhranous
nephropathy showed a subnormal phagocytic capacity. By
comparison, monocytes of four of the ten patients with mesan-
gial proliferative glomerulonephritis exhibited a depressed ahi Ii-
ty to ingest EAIgG particles. The calculated mean (± SD)
percentages of monocytes exhibiting phagocytosis of sensitized
erythrocytes for the normal subjects, patients with mesangial
proliferative glomerulonephritis, membranous nephropathy,
and chronic renal failure were 89% + 5%, 72% 17%, 87%
8%, and 90% 6%, respectively. Statistical analysis by Stu-
dent's t test showed a significant difference between the mean
percentage from patients with mesangial proliferative glomeru-
lonephritis and the mean percentages of normal subjects (t =
3.10, P < 0.01), patients with membranous nephropathy (t —
2.43, P < 0.02), and with chronic renal failure (t — 3.04, P <
0.01). However, if the comparisons were made between the
mean of the six patients with mesangial proliferative glomerulo-
nephritis without the monocyte phagocytic defect and the
means of the other three groups, the differences were no longer
3
4
5
Serum
albumin
(g/dl)
Serum
creatinine
(rng/dI)
Latex
bead
phagocy-
tosis 9/ CIC
2.8 1.0 32
2.9 0.9 56
3.1 2.7 72
3.2 10.0 64
1.7 1.3 76
Monocyte phagocytic defect in nephritis 853
significant suggesting that the group mean differences were
entirely due to the values obtained for the four patients with the
monocyte phagocyte defect. Incubation of the sera (20%) of
these four patients (with the phagocytic defect) with monocytes
from healthy subjects for 1 to 2 hr did not induce a defect in
phagocytic ability when compared with the results obtained by
incubation of normal monocytes with normal sera.
The results of the assay for latex bead phagocytosis are
shown in Figure 2. In normal subjects the mean (± SD)
percentage of monocytes exhibiting phagocytosis of latex beads
was 89% 4%. Monocytes from two of the patients with
mesangial proliferative glomerulonephritis who had an Fc re-
ceptor defect also had a subnormal ability to ingest latex beads
(Table 1). There were no statistical differences observed be-
tween the means of the groups of subjects studied.
The clinical characteristics of the five patients with the
phagocytic defect are shown in Table 1 with a comparison of the
characteristics of the other patients with various forms of
chronic renal failure or the nephrotic syndrome. No differences
were discernible between the group with the defect and the
patient controls, except that the single patient with membra-
nous nephropathy exhibiting the phagocytic defect had the
lowest serum albumin concentration of all patients studied.
Discussion
The data in this study clearly show that a subpopulation of
patients with nephritis have a defect in monocyte Fc receptor
function as demonstrated by an in vitro technique monitoring
the capacity of these cells to ingest sheep erythrocytes coated
with IgG antibody. Four of the ten patients with mesangial
proliferative glomerulonephritis exhibited this defect. Addition-
ally, a defect in phagocytizing latex beads was detected in two
of these four patients. By comparison, only one of the eight
patients with membranous nephropathy had a demonstrable
monocyte phagocytic defect.
The reasons for these phagocytic defects are unclear. In one
patient with mesangial proliferative glomerulonephritis, the
presence of immune complexes in the sera could be responsible
by occupying Fc receptor sites. Comparison studies with pa-
tients exhibiting the nephrotic syndrome due to membranous
nephropathy (in the group with normal Fc receptor function)
exclude protein depletion as a cause since comparable serum
albumin levels were observed in both groups. This is underlined
by the fact that the patient with membranous nephropathy who
had a severely lowered serum albumin had only a marginal Fc
receptor defect. Furthermore, the defect could not be induced
by incubating normal monocytes with nephrotic sera. Similarly,
uremia could be excluded as a contributing cause from a study
of monocyte phagocyte function of uremic subjects.
The significance of these observations relate to the role of the
mononuclear phagocyte system in the genesis of nephritis. An
Fc receptor defect in the mononuclear phagocyte system would
more readily allow the saturation of this system by antigen-
antibody complexes with overflow into the kidney. Experimen-
tal studies have also shown an important function of the
monocyte/macrophage in the local removal of such complexes,
such that an impairment of the Fc receptor would allow the
persistence of these tissue deposits [20]. It is attractive to
speculate that the differential expression of immune complex
nephritis as exemplified by mernbranous nephropathy and
mesangial proliferative glomerulonephritis may at least in part
be due to the functional status of the monocyte Fc receptor.
Since a substantial proportion of patients with mesangial prolif-
erative glomerulonephritis do not have such a demonstrable
defect, other factors must also be involved.
The identification of a subpopulation of patients with a
monocyte phagocytic defect also brings into focus the contin-
ued substantiation of the hypothesis proposed by Peters and
Lachmann that nephritis may occur in states of immune defi-
ciency [21]. There are now several areas of evidence to support
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Fig. 1. Phagocytosis of EIgGSRBC by monocytes of normal subjects
and of patients with various forms of renal disease. Bars in control
panel represent mean 2 SD.
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Fig. 2. Phagocytosis of latex beads of control subjects and patients with
various forms of kidney disease. Bars in control panel represent mean
2 SD.
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such a hypothesis..he association between the occurrence of
vasculiti s-nephritis in patients with inherited complement defi-
ciencies is well established [221. One of the important functions
of complement in this context is the solubilization of immune
complexes [23] and recent investigations have shown a relation-
ship between activity of nephritis and this complement function
[24]. In addition to complement deficiency in nephritis, studies
in our laboratory have shown that patients with membranous
nephropathy have an in vitro defect of immunoglobulin synthe-
sis on stimulation of their peripheral blood lymphocytes by the
polyclonal activator, pokeweed mitogen, and that the defect is
mediated by a population of monocyte-suppressor cells [25].
These observations are indirectly corroborated by the report of
Carney et al [261 who found that a substantial population of
patients with nephritis generate a reduced antibody response to
tetanus toxoid as compared to controls. In addition, other
functional lymphocyte abnormalities, such as the response of
these cells to phytohemagglutinin, were also discovered. It is in
this context that our finding of a subpopulation of patients with
a monocyte Fc receptor defect must be interpreted. This
subpopulation may represent a segment of patients in the
continuum of patients with a variety of immune deficiencies.
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